For reference materials and more information relating to peripheral T-cell lymphoma, consult the resources listed below.
Armitage JO. The aggressive peripheral T‐cell lymphomas: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012;87:511‐519.
Berman S, Vose JM. T‐cell lymphomas: Moving forward, improving outcomes: An expert interview with Julie M. Vose. Medscape. http://www.medscape.com/viewarticle/777818_print. Published January 23, 2013. Accessed February 7, 2014.
British Committee for Standards in Haematology. Guidelines for the management of mature T‐cell and NK‐cell neoplasms. http://www.bcshguidelines.com/documents/T‐cell_guideline_final_bcsh.pdf. Published June 2013. Accessed February 6, 2014.
Chan TS. Novel therapeutic agents for T‐cell lymphomas. Discovery Med. 2013;17.
Gambacorti‐Passerini C, Horibe K, Braiteh F, et al. Safety and clinical activity of crizotinib in patients with ALK-rearranged hematologic malignancies. Presented at the 55th ASH Annual Meeting and Exposition; December7-10, 2013;New Orleans, Louisiana.
Horwitz S, Dogan A. A pathologist’s guide to the accurate diagnosis of peripheral T‐cell lymphomas. Medscape. http://www.medscape.org/viewarticle/818081. Published January 2, 2014. Accessed January 7, 2014.
Horwitz SM. Commentary: Viewpoint: Molecular profiling improves classification of nodal peripheral T‐cell lymphomas. ASCO Post. September 1, 2012;4. http://www.ascopost.com/issues/september‐1,‐2013/commentary‐viewpoint‐molecular‐profiling‐improves‐classification‐of‐nodal‐peripheral‐t‐celllymphomas.aspx 1. Accessed February 6, 2014.
Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology. 2009;2009(1):523-531. doi:10.1182/asheducation-2009.1.523.
Jaffe ES. Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma. J Clin Oncol. 2011;29:1398‐1399.
Tang T, Tay K, Quek R, et al. Peripheral T‐cell lymphoma: review and updates of current management strategies. Adv. Hematology. 2010;2010:624040. Published Dec 30, 2010.
Lymphoma Coalition. Global patient survey: lymphoma survey analysis for United States of America. Lymphoma Coalition. http://www.lymphomacoalition.org/research/global‐patient‐survey. Published 2012. Accessed January 7, 2014.
Lymphoma Research Foundation. Peripheral T‐Cell Lymphoma (PTCL). Lymphoma Research Foundation. http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6300159. Accessed February 11, 2014.
Lymphoma Research Foundation. T‐cell lymphomas: Overview. Lymphoma Research Foundation. http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6300161. Published 2012. Accessed January 7, 2014.
Pileri SA, Piccaluga PP. New molecular insights into peripheral T cell lymphomas. J Clin Investig. 2012;122:3448‐3455.
Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008.
Wilkins BS. Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues. J Clin Pathol. 2011;64:466‐476.
Zelenetz AS, Gordon LI, Wierda WG, et al. NCCN clinical practice guidelines in oncology: non‐Hodgkin’s lymphomas. http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf. Published 2014. Accessed February 7, 2014.